Insiders · Profile

Van Naarden Jacob

EVP & Pres., Lilly Oncology at Lilly (Eli). Filing since 13 Aug 2025. CIK 0001661254

Company
Date
Role
Action
Shares
Amount
Of holding
13 Aug 2025
EVP & Pres., Lilly Oncology
Bought
1,000
$647.36K
5.1%
1 decision on file.